Evidence map›Paper›PMID 40542814›Full record

ArticleJACC. CardioOncology2025

Mismatch Between Preclinical Cardio-Oncology and Clinical Oncology Research.

Rachele Cagnazzo, Mario Stabile, Gabriele Zoppoli, Rudolf A De Boer, Wouter C Meijers, Peter van Der Meer, Pietro Ameri

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. CardioOncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Caught in the crossfire: cardiac complications of cancer therapy.The Journal of clinical investigation · 2026
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rachele CagnazzoCardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Mario StabileDepartment of Internal Medicine, University of Genova, Genova, Italy.
Gabriele ZoppoliDepartment of Internal Medicine, University of Genova, Genova, Italy; Internal Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Rudolf A De BoerErasmus MC, Cardiovascular Institute, Thorax Center, Department of Cardiology, Rotterdam, the Netherlands.
Wouter C MeijersErasmus MC, Cardiovascular Institute, Thorax Center, Department of Cardiology, Rotterdam, the Netherlands.
Peter van Der MeerDepartment of Cardiology, University Medical Center Groningen, Groningen, the Netherlands.
Pietro AmeriCardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine, University of Genova, Genova, Italy. Electronic address: pietroameri@unige.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancercardiotoxicitydesignfundingmethodology

Identifiers

PMID40542814
PMCPMC12790043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.